Table 2.
Comparison of demographic and medical variables with the pulmonary involvement of all abnormalities based on lung computed tomography.
| Pulmonary involvement of all abnormalities |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| <10% |
10-25% |
25-50% |
>50% |
||||||
| n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
n,% |
P-value OR (95% CI) |
||
|
Age groups (n, %) |
<60 (n = 79) |
35 (44.3) | >0.05 1.12 (0.78-1.62) |
32 (40.5) | >0.05 0.80 (0.57-1.13) |
04 (5.1) |
>0.05 1.03 (0.95-1.11) |
08 (10.1) | >0.05 0.92 (0.85-1.00) |
| ≥60 (n = 81) |
32 (39.5) | 41 (50.6) | 06 (7.4) |
02 (2.5) | |||||
|
Variants (n, %) |
Alpha (n = 26) |
13 (50.0) | >0.05 | 06 (23.1) | <0.05 | 04 (15.4) | <0.05 | 03 (11.5) | <0.05 |
| Delta (n = 98) |
36 (36.7) | 50 (51.0) | 06 (6.1) | 06 (6.1) | |||||
| Omicron (n = 36) |
18 (50.0) | 17 (47.2) | 0 (0.0) | 01 (2.8) | |||||
| Vaccine | None (n = 105) |
50 (47.6) | >0.05 | 41 (39.0) |
<0.05 | 09 (8.6) |
>0.05 | 05 (4.0) |
>0.05 |
| 1 dose (n = 17) |
05 (29.4) | 08 (47.1) | 01 (5.9) | 03 (17.5) | |||||
| ≥2 doses (n = 38) |
12 (31.6) | 24 (63.2) | 00 (0.0) | 02 (5.3) | |||||
| Oxygen therapies | Not used (n = 68) |
42 (61.8) | <0.05 | 21 (30.9) |
<0.05 | 03 (4.4) |
>0.05 | 02 (2.9) | <0.05 |
| Mask cannula (n = 68) |
19 (27.9) | 37 (54.4) |
04 (5.9) |
08 (11.8) | |||||
| Ventilator (n = 24) |
06 (25.0) | 15 (62.5) |
03 (12.5) |
0 (0.0) |
|||||
| Severities | Non severe (n = 72) |
45 (62.5) |
<0.001 2.00 (1.45-2.76) |
22 (30.6) |
<0.001 3.13 (1.63-6.04) |
03 (4.2) | >0.05 0.96 (0.89-1.04) |
02 (2.8) |
>0.05 0.94 (0.87-1.01) |
| Severe (n = 88) |
22 (25.0) |
51 (58.0) |
07 (8.0) | 08 (9.1) |
|||||
| Treatment outcomes | Survive (n = 140) |
63 (45.0) |
<0.05 2.25 (0.92-5.51) |
60 (42.9) |
>0.05 1.63 (0.88-3.02) |
08 (5.7) |
>0.05 1.63 (0.88-3.02) |
09 (6.4) |
>0.05 0.99 (0.88-1.10) |
| Death (n = 20) |
04 (20.0) | 13 (65.0) |
02 (10.0) |
01 (5.0) | |||||
CI, confidence interval; OR, odds ratio.